| scholarly article | Q13442814 |
| P2093 | author name string | E S Vizi | |
| A L Salzman | |||
| C Szabó | |||
| G Haskó | |||
| Z H Németh | |||
| B Zingarelli | |||
| V Kvetan | |||
| S M Pastores | |||
| P2860 | cites work | Arachidonic acid metabolism in endotoxin tolerance. | Q33478031 |
| Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. | Q36364202 | ||
| Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia | Q37351701 | ||
| Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells | Q40334243 | ||
| Is it time to reposition vasopressors and inotropes in sepsis? | Q40984469 | ||
| Cytokine production and its manipulation by vasoactive drugs. | Q41085387 | ||
| Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. | Q41151273 | ||
| Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform | Q41233331 | ||
| Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. | Q41254098 | ||
| Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines | Q41513679 | ||
| Nitric Oxide Production by Murine Macrophages Is Inhibited by Prolonged Elevation of Cyclic AMP | Q41528064 | ||
| Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists | Q41622626 | ||
| Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock | Q42920901 | ||
| Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. | Q48300313 | ||
| Differential effect of selective block of alpha 2-adrenoreceptors on plasma levels of tumour necrosis factor-alpha, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice | Q49172318 | ||
| Activation of soluble guanylyl cyclase by a factor other than nitric oxide or carbon monoxide contributes to the vascular hyporeactivity to vasoconstrictor agents in the aorta of rats treated with endotoxin. | Q50772503 | ||
| Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity. | Q53801070 | ||
| NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. | Q54191614 | ||
| A comparison of dopamine, dobutamine and isoproterenol in the treatment of shock. | Q54457886 | ||
| Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil | Q70464388 | ||
| Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by dopamine receptor agonists and antagonists in mice | Q71343756 | ||
| IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury | Q71586931 | ||
| Effects of a nitric oxide synthase inhibitor in humans with septic shock | Q71611483 | ||
| Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs | Q71714659 | ||
| Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury | Q71736276 | ||
| Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α- and β-adrenergic drugs in mice | Q71825959 | ||
| Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide | Q72101813 | ||
| Beta Adrenergic Agonists | Q72527586 | ||
| Differential regulatory effects of adenosine on cytokine release by activated human monocytes | Q72727495 | ||
| Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge | Q72817275 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| TNF | Q18032037 | ||
| P304 | page(s) | 95-100 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Immunology | Q15754984 |
| P1476 | title | Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia | |
| P478 | volume | 90 |
| Q62489619 | Adrenaline inhibits macrophage nitric oxide production through beta1 and beta2 adrenergic receptors |
| Q43920737 | Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-alpha and interleukin-10. |
| Q44902172 | Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis |
| Q40748854 | Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia |
| Q46580831 | Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers |
| Q47830248 | Calcium channel blockers and dantrolene differentially regulate the production of interleukin-12 and interferon-gamma in endotoxemic mice. |
| Q38770352 | Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system |
| Q34221106 | Cytokines and the central nervous system |
| Q73449218 | Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and beta-adrenoceptors in mice |
| Q36902534 | Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flow |
| Q46589738 | Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta. |
| Q28369430 | Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism |
| Q28533928 | Identification of pharmacological modulators of HMGB1-induced inflammatory response by cell-based screening |
| Q33870763 | Immune changes in humans during cold exposure: effects of prior heating and exercise |
| Q37382778 | Impaired norepinephrine regulation of monocyte inflammatory cytokine balance in heart failure |
| Q41069663 | Isoproterenol inhibits Il-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages |
| Q35598201 | Key role of the sympathetic microenvironment for the interplay of tumour necrosis factor and interleukin 6 in normal but not in inflamed mouse colon mucosa |
| Q35018088 | Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis |
| Q35051206 | Macrophages and post-burn immune dysfunction |
| Q33631375 | Nitric oxide in septic shock |
| Q88154378 | Noradrenergic Modulation on Dopaminergic Neurons |
| Q34391616 | Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications. |
| Q34784409 | Noradrenergic regulation of inflammatory gene expression in brain. |
| Q34582310 | Present concepts on the inflammatory modulators with special reference to cytokines |
| Q35041523 | Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS 49, in rat vascular smooth muscle and RAW 264.7 macrophages |
| Q34999623 | Prospective, randomized trial comparing fluids and dobutamine optimization of oxygen delivery in high-risk surgical patients [ISRCTN42445141] |
| Q34431888 | Receptor-mediated interaction between the sympathetic nervous system and immune system in inflammation |
| Q47823802 | Receptor-mediated local fine-tuning by noradrenergic innervation of neuroendocrine and immune systems. |
| Q77512461 | Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system |
| Q44732744 | Salmeterol, a beta2-receptor agonist, attenuates lipopolysaccharide-induced lung inflammation in mice |
| Q42376445 | Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening |
| Q47750973 | Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice |
| Q30426928 | Stress in the adult rat exacerbates muscle pain induced by early-life stress |
| Q59309802 | Suppression of the acute inflammatory response of porcine alveolar‐ and liver macrophages |
| Q47852618 | Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury |
| Q36552147 | Sympathetic modulation of immunity: relevance to disease |
| Q90529594 | Targeting of G-protein coupled receptors in sepsis |
| Q38986446 | The clinically used poly(ADP-ribose) polymerase (PARP) inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury. |
| Q38770211 | The effects of acute psychological stress on circulating and stimulated inflammatory markers: A systematic review and meta-analysis |
| Q36822309 | The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease |
| Q34340565 | The process of aging changes the interplay of the immune, endocrine and nervous systems. |
| Q35106477 | The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials? |
| Q33862430 | The role of tumor necrosis factor in the pathophysiology of heart failure |
| Q35413675 | The sympathetic nervous response in inflammation |
| Q48685237 | The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus |
| Q38906880 | Treatment of endotoxaemia and septicaemia in the equine patient |
| Q36147248 | Use of inotropes and vasopressor agents in critically ill patients. |
Search more.